1	Endosialin/TEM	_	NN	_	_	3	VMOD	_	_
2	1/CD248	_	CD	_	_	1	NMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	a	_	DT	_	_	6	NMOD	_	_
5	pericyte	_	JJ	_	_	6	NMOD	_	_
6	marker	_	NN	_	_	3	VMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	embryonic	_	JJ	_	_	11	NMOD	_	_
9	and	_	CC	_	_	11	COORD	_	_
10	tumor	_	NN	_	_	11	COORD	_	_
11	neovascularization	_	NN	_	_	7	PMOD	_	_
12	.	_	.	_	_	3	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	formation	_	NN	_	_	9	VMOD	_	_
3	of	_	IN	_	_	2	NMOD	_	_
4	functional	_	JJ	_	_	8	NMOD	_	_
5	,	_	,	_	_	4	P	_	_
6	mature	_	JJ	_	_	4	COORD	_	_
7	blood	_	NN	_	_	8	NMOD	_	_
8	vessels	_	NNS	_	_	3	PMOD	_	_
9	depends	_	VBZ	_	_	0	ROOT	_	_
10	on	_	IN	_	_	9	VMOD	_	_
11	the	_	DT	_	_	12	NMOD	_	_
12	interaction	_	NN	_	_	10	PMOD	_	_
13	between	_	IN	_	_	12	NMOD	_	_
14	endothelial	_	JJ	_	_	15	NMOD	_	_
15	cells	_	NNS	_	_	13	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	pericytes	_	NNS	_	_	16	CONJ	_	_
18	.	_	.	_	_	9	P	_	_
		
1	Commonality	_	NN	_	_	2	VMOD	_	_
2	exists	_	VBZ	_	_	0	ROOT	_	_
3	in	_	IN	_	_	2	VMOD	_	_
4	the	_	DT	_	_	5	NMOD	_	_
5	processes	_	NNS	_	_	3	PMOD	_	_
6	involved	_	VBN	_	_	5	APPO	_	_
7	in	_	IN	_	_	6	VMOD	_	_
8	vasculature	_	NN	_	_	9	NMOD	_	_
9	development	_	NN	_	_	7	PMOD	_	_
10	between	_	IN	_	_	9	NMOD	_	_
11	tissues	_	NNS	_	_	10	PMOD	_	_
12	whether	_	IN	_	_	2	VMOD	_	_
13	healthy	_	JJ	_	_	12	SUB	_	_
14	or	_	CC	_	_	13	COORD	_	_
15	diseased	_	JJ	_	_	14	CONJ	_	_
16	.	_	.	_	_	2	P	_	_
		
1	Endosialin/TEM	_	NN	_	_	3	VMOD	_	_
2	1	_	CD	_	_	1	NMOD	_	_
3	is	_	VBZ	_	_	0	ROOT	_	_
4	a	_	DT	_	_	7	NMOD	_	_
5	cell	_	NN	_	_	7	NMOD	_	_
6	membrane	_	NN	_	_	7	NMOD	_	_
7	protein	_	NN	_	_	3	VMOD	_	_
8	that	_	WDT	_	_	9	VMOD	_	_
9	is	_	VBZ	_	_	7	NMOD	_	_
10	expressed	_	VBN	_	_	9	VC	_	_
11	in	_	IN	_	_	10	VMOD	_	_
12	blood	_	NN	_	_	13	NMOD	_	_
13	vessels	_	NNS	_	_	11	PMOD	_	_
14	during	_	IN	_	_	10	VMOD	_	_
15	embryogenesis	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	tumorigenesis	_	NN	_	_	16	CONJ	_	_
18	but	_	CC	_	_	14	COORD	_	_
19	not	_	RB	_	_	20	DEP	_	_
20	in	_	IN	_	_	18	CONJ	_	_
21	normal	_	JJ	_	_	23	NMOD	_	_
22	mature	_	JJ	_	_	23	NMOD	_	_
23	vessels	_	NNS	_	_	20	PMOD	_	_
24	.	_	.	_	_	3	P	_	_
		
1	Antibodies	_	NNS	_	_	6	VMOD	_	_
2	developed	_	VBN	_	_	1	APPO	_	_
3	to	_	TO	_	_	2	VMOD	_	_
4	human	_	JJ	_	_	5	NMOD	_	_
5	endosialin	_	NN	_	_	3	PMOD	_	_
6	were	_	VBD	_	_	0	ROOT	_	_
7	used	_	VBN	_	_	6	VC	_	_
8	to	_	TO	_	_	7	VMOD	_	_
9	investigate	_	VB	_	_	8	IM	_	_
10	endosialin	_	NN	_	_	11	NMOD	_	_
11	expression	_	NN	_	_	9	VMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	function	_	NN	_	_	12	CONJ	_	_
14	in	_	IN	_	_	11	NMOD	_	_
15	human	_	JJ	_	_	18	NMOD	_	_
16	prenatal	_	JJ	_	_	18	NMOD	_	_
17	brain	_	NN	_	_	18	NMOD	_	_
18	pericytes	_	NNS	_	_	14	PMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	pericytes	_	NNS	_	_	19	CONJ	_	_
21	residing	_	VBG	_	_	20	APPO	_	_
22	in	_	IN	_	_	21	VMOD	_	_
23	tumors	_	NNS	_	_	22	PMOD	_	_
24	.	_	.	_	_	6	P	_	_
		
1	Anti-endosialin	_	NN	_	_	2	VMOD	_	_
2	was	_	VBD	_	_	0	ROOT	_	_
3	capable	_	JJ	_	_	2	VMOD	_	_
4	of	_	IN	_	_	3	AMOD	_	_
5	preventing	_	VBG	_	_	4	PMOD	_	_
6	pericyte	_	NN	_	_	8	NMOD	_	_
7	tube	_	NN	_	_	8	NMOD	_	_
8	formation	_	NN	_	_	5	VMOD	_	_
9	in	_	IN	_	_	8	NMOD	_	_
10	culture	_	NN	_	_	9	PMOD	_	_
11	and	_	CC	_	_	2	COORD	_	_
12	inhibited	_	VBD	_	_	11	CONJ	_	_
13	migration	_	NN	_	_	12	VMOD	_	_
14	.	_	.	_	_	2	P	_	_
		
1	Brain	_	NN	_	_	2	NMOD	_	_
2	pericytes	_	NNS	_	_	5	VMOD	_	_
3	in	_	IN	_	_	2	NMOD	_	_
4	culture	_	NN	_	_	3	PMOD	_	_
5	had	_	VBD	_	_	0	ROOT	_	_
6	higher	_	JJR	_	_	7	NMOD	_	_
7	levels	_	NNS	_	_	5	VMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	endosialin/TEM	_	NN	_	_	8	PMOD	_	_
10	1	_	CD	_	_	9	NMOD	_	_
11	than	_	IN	_	_	5	VMOD	_	_
12	TEMs-2	_	NN	_	_	11	PMOD	_	_
13	,	_	,	_	_	12	P	_	_
14	-3	_	CD	_	_	12	NMOD	_	_
15	,	_	,	_	_	14	P	_	_
16	-4	_	CD	_	_	14	COORD	_	_
17	,	_	,	_	_	16	P	_	_
18	-5	_	CD	_	_	16	COORD	_	_
19	,	_	,	_	_	18	P	_	_
20	-7	_	CD	_	_	18	COORD	_	_
21	,	_	,	_	_	20	P	_	_
22	and	_	CC	_	_	20	COORD	_	_
23	-8	_	CD	_	_	22	CONJ	_	_
24	.	_	.	_	_	5	P	_	_
		
1	Immunocytochemistry	_	NN	_	_	2	VMOD	_	_
2	revealed	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	endosialin	_	NN	_	_	5	VMOD	_	_
5	was	_	VBD	_	_	3	SUB	_	_
6	present	_	JJ	_	_	5	VMOD	_	_
7	in	_	IN	_	_	6	AMOD	_	_
8	the	_	DT	_	_	10	NMOD	_	_
9	cytoplasmic	_	JJ	_	_	10	NMOD	_	_
10	body	_	NN	_	_	7	PMOD	_	_
11	and	_	CC	_	_	7	COORD	_	_
12	in	_	IN	_	_	11	CONJ	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	elongated	_	VBN	_	_	15	NMOD	_	_
15	extensions	_	NNS	_	_	12	PMOD	_	_
16	essential	_	JJ	_	_	15	APPO	_	_
17	to	_	TO	_	_	16	AMOD	_	_
18	pericyte	_	NN	_	_	19	NMOD	_	_
19	function	_	NN	_	_	17	PMOD	_	_
20	.	_	.	_	_	2	P	_	_
		
1	Transgenic	_	JJ	_	_	2	NMOD	_	_
2	mice	_	NNS	_	_	13	VMOD	_	_
3	engineered	_	VBN	_	_	2	APPO	_	_
4	to	_	TO	_	_	3	VMOD	_	_
5	express	_	VB	_	_	4	IM	_	_
6	human	_	JJ	_	_	7	NMOD	_	_
7	endosialin	_	NN	_	_	5	VMOD	_	_
8	bred	_	VBN	_	_	7	APPO	_	_
9	on	_	IN	_	_	8	VMOD	_	_
10	an	_	DT	_	_	12	NMOD	_	_
11	immunocompromised	_	JJ	_	_	12	NMOD	_	_
12	background	_	NN	_	_	9	PMOD	_	_
13	allowed	_	VBD	_	_	0	ROOT	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	growth	_	NN	_	_	13	VMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	human	_	JJ	_	_	19	NMOD	_	_
18	tumor	_	NN	_	_	19	NMOD	_	_
19	xenografts	_	NNS	_	_	16	PMOD	_	_
20	.	_	.	_	_	13	P	_	_
		
1	In	_	IN	_	_	17	VMOD	_	_
2	human	_	JJ	_	_	8	NMOD	_	_
3	colon	_	NN	_	_	8	NMOD	_	_
4	carcinoma	_	NN	_	_	8	NMOD	_	_
5	Colo205	_	NN	_	_	8	NMOD	_	_
6	and	_	CC	_	_	5	COORD	_	_
7	HT29	_	NN	_	_	6	CONJ	_	_
8	xenografts	_	NNS	_	_	1	PMOD	_	_
9	grown	_	VBN	_	_	8	APPO	_	_
10	in	_	IN	_	_	9	VMOD	_	_
11	human	_	JJ	_	_	13	NMOD	_	_
12	endosialin-transgenic	_	JJ	_	_	13	NMOD	_	_
13	mice	_	NNS	_	_	10	PMOD	_	_
14	,	_	,	_	_	17	P	_	_
15	endosialin	_	NN	_	_	16	NMOD	_	_
16	expression	_	NN	_	_	17	VMOD	_	_
17	was	_	VBD	_	_	0	ROOT	_	_
18	largely	_	RB	_	_	17	VMOD	_	_
19	confined	_	VBN	_	_	17	VC	_	_
20	to	_	TO	_	_	19	VMOD	_	_
21	NG2-expressing	_	JJ	_	_	23	NMOD	_	_
22	perivascular	_	JJ	_	_	23	NMOD	_	_
23	cells	_	NNS	_	_	20	PMOD	_	_
24	and	_	CC	_	_	23	COORD	_	_
25	not	_	RB	_	_	28	NMOD	_	_
26	CD31-positive	_	JJ	_	_	28	NMOD	_	_
27	endothelial	_	JJ	_	_	28	NMOD	_	_
28	cells	_	NNS	_	_	24	CONJ	_	_
29	.	_	.	_	_	17	P	_	_
		
1	Similar	_	JJ	_	_	2	NMOD	_	_
2	methods	_	NNS	_	_	10	VMOD	_	_
3	applied	_	VBN	_	_	2	APPO	_	_
4	to	_	TO	_	_	3	VMOD	_	_
5	human	_	JJ	_	_	9	NMOD	_	_
6	ovarian	_	JJ	_	_	9	NMOD	_	_
7	and	_	CC	_	_	6	COORD	_	_
8	colon	_	NN	_	_	7	CONJ	_	_
9	tumors	_	NNS	_	_	4	PMOD	_	_
10	confirmed	_	VBD	_	_	0	ROOT	_	_
11	endosialin	_	NN	_	_	12	NMOD	_	_
12	expression	_	NN	_	_	10	VMOD	_	_
13	by	_	IN	_	_	10	VMOD	_	_
14	pericytes	_	NNS	_	_	13	PMOD	_	_
15	.	_	.	_	_	10	P	_	_
		
1	The	_	DT	_	_	2	NMOD	_	_
2	data	_	NNS	_	_	3	VMOD	_	_
3	indicate	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	endosialin	_	NN	_	_	6	VMOD	_	_
6	is	_	VBZ	_	_	4	SUB	_	_
7	strongly	_	RB	_	_	6	VMOD	_	_
8	expressed	_	VBN	_	_	6	VC	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	pericytes	_	NNS	_	_	9	PMOD	_	_
11	during	_	IN	_	_	8	VMOD	_	_
12	periods	_	NNS	_	_	11	PMOD	_	_
13	of	_	IN	_	_	12	NMOD	_	_
14	active	_	JJ	_	_	15	NMOD	_	_
15	angiogenesis	_	NN	_	_	13	PMOD	_	_
16	during	_	IN	_	_	8	VMOD	_	_
17	embryonic	_	JJ	_	_	20	NMOD	_	_
18	and	_	CC	_	_	20	COORD	_	_
19	tumor	_	NN	_	_	20	COORD	_	_
20	development	_	NN	_	_	16	PMOD	_	_
21	.	_	.	_	_	3	P	_	_
		
1	Anti-endosialin	_	NN	_	_	2	NMOD	_	_
2	antibodies	_	NNS	_	_	3	VMOD	_	_
3	may	_	MD	_	_	0	ROOT	_	_
4	have	_	VB	_	_	3	VC	_	_
5	value	_	NN	_	_	4	VMOD	_	_
6	in	_	IN	_	_	4	VMOD	_	_
7	identifying	_	VBG	_	_	6	PMOD	_	_
8	vasculature	_	NN	_	_	7	VMOD	_	_
9	in	_	IN	_	_	7	VMOD	_	_
10	malignant	_	JJ	_	_	11	NMOD	_	_
11	tissues	_	NNS	_	_	9	PMOD	_	_
12	.	_	.	_	_	3	P	_	_
		
1	With	_	IN	_	_	8	VMOD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	appropriate	_	JJ	_	_	4	NMOD	_	_
4	agent	_	NN	_	_	1	PMOD	_	_
5	,	_	,	_	_	8	P	_	_
6	targeting	_	NN	_	_	7	NMOD	_	_
7	endosialin	_	NN	_	_	8	VMOD	_	_
8	may	_	MD	_	_	0	ROOT	_	_
9	interfere	_	VB	_	_	8	VC	_	_
10	with	_	IN	_	_	9	VMOD	_	_
11	blood	_	NN	_	_	13	NMOD	_	_
12	vessel	_	NN	_	_	13	NMOD	_	_
13	growth	_	NN	_	_	10	PMOD	_	_
14	during	_	IN	_	_	9	VMOD	_	_
15	tumor	_	NN	_	_	16	NMOD	_	_
16	development	_	NN	_	_	14	PMOD	_	_
17	.	_	.	_	_	8	P	_	_
		
